{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T13:01:59Z","timestamp":1790686919928,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1136\/ard.2010.138693","type":"journal-article","created":{"date-parts":[[2011,2,15]],"date-time":"2011-02-15T09:19:49Z","timestamp":1297761589000},"page":"733-739","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":172,"title":["Physical disability in rheumatoid arthritis is associated with cartilage damage rather than bone destruction"],"prefix":"10.1016","volume":"70","author":[{"given":"Daniel","family":"Aletaha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Funovits","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josef S","family":"Smolen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ard.2010.138693_bib1","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1002\/1529-0131(199909)42:9<1854::AID-ANR9>3.0.CO;2-F","article-title":"Long-term course and outcome of functional capacity in rheumatoid arthritis: the effect of disease activity and radiologic damage over time.","volume":"42","author":"Drossaers-Bakker","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2010.138693_bib2","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1002\/1529-0131(200109)44:9<2009::AID-ART349>3.0.CO;2-L","article-title":"The relationship between disease activity, joint destruction, and functional capacity over the course of rheumatoid arthritis.","volume":"44","author":"Welsing","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2010.138693_bib3","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1136\/ard.2003.012575","article-title":"Patients with rheumatoid arthritis in clinical care.","volume":"63","author":"Smolen","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2010.138693_bib4","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1002\/art.22052","article-title":"Measuring function in rheumatoid arthritis: identifying reversible and irreversible components.","volume":"54","author":"Aletaha","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2010.138693_bib5","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1136\/ard.2009.118430","article-title":"Impact of comorbidity on physical function in patients with rheumatoid arthritis.","volume":"69","author":"Radner","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2010.138693_bib6","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1136\/ard.2007.081331","article-title":"Level of radiographic damage and radiographic progression are determinants of physical function: a longitudinal analysis of the TEMPO trial.","volume":"67","author":"van der Heijde","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2010.138693_bib7","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1136\/ard.2009.114652","article-title":"Estimation of a numerical value for joint damage-related physical disability in rheumatoid arthritis clinical trials.","volume":"69","author":"Smolen","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2010.138693_bib8","first-page":"943","article-title":"Identification of cell types responsible for bone resorption in rheumatoid arthritis and juvenile rheumatoid arthritis.","volume":"152","author":"Gravallese","year":"1998","journal-title":"Am J Pathol"},{"key":"10.1136\/ard.2010.138693_bib9","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1172\/JCI0215582","article-title":"Osteoclasts are essential for TNF-alpha-mediated joint destruction.","volume":"110","author":"Redlich","year":"2002","journal-title":"J Clin Invest"},{"issue":"Suppl 2","key":"10.1136\/ard.2010.138693_bib10","first-page":"ii11","article-title":"Pathogenesis of bone and cartilage destruction in rheumatoid arthritis.","volume":"42","author":"Goldring","year":"2003","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/ard.2010.138693_bib11","doi-asserted-by":"crossref","first-page":"363","DOI":"10.2174\/1568010054022141","article-title":"Matrix metalloproteinase knockout studies and the potential use of matrix metalloproteinase inhibitors in the rheumatic diseases.","volume":"4","author":"Milner","year":"2005","journal-title":"Curr Drug Targets Inflamm Allergy"},{"key":"10.1136\/ard.2010.138693_bib12","doi-asserted-by":"crossref","first-page":"R31","DOI":"10.1186\/ar1882","article-title":"Radiographic joint damage in rheumatoid arthritis is associated with differences in cartilage turnover and can be predicted by serum biomarkers: an evaluation from 1 to 4 years after diagnosis.","volume":"8","author":"Verstappen","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"10.1136\/ard.2010.138693_bib13","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1002\/art.1780140605","article-title":"Methods of scoring the progression of radiologic changes in rheumatoid arthritis. Correlation of radiologic, clinical and laboratory abnormalities.","volume":"14","author":"Sharp","year":"1971","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2010.138693_bib14","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1136\/ard.2008.094128","article-title":"Progression of radiographic joint damage in rheumatoid arthritis: independence of erosions and joint space narrowing.","volume":"68","author":"Smolen","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2010.138693_bib15","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","article-title":"The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.","volume":"31","author":"Arnett","year":"1988","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2010.138693_bib16","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1136\/ard.2010.138461","article-title":"2010 rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative.","volume":"69","author":"Aletaha","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2010.138693_bib17","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.27584","article-title":"2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative.","volume":"62","author":"Aletaha","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2010.138693_bib18","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1056\/NEJM200011303432202","article-title":"Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group.","volume":"343","author":"Lipsky","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1136\/ard.2010.138693_bib19","doi-asserted-by":"crossref","first-page":"3432","DOI":"10.1002\/art.20568","article-title":"Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: a randomized, controlled trial.","volume":"50","author":"St Clair","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2010.138693_bib20","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1002\/art.20217","volume":"50","author":"Keystone","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2010.138693_bib21","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/art.21519","volume":"54","author":"Breedveld","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2010.138693_bib22","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0140-6736(04)15640-7","article-title":"Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial.","volume":"363","author":"Klareskog","year":"2004","journal-title":"Lancet"},{"key":"10.1136\/ard.2010.138693_bib23","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0140-6736(98)09403-3","article-title":"Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a double-blind, randomised, multicentre trial. European Leflunomide Study Group.","volume":"353","author":"Smolen","year":"1999","journal-title":"Lancet"},{"key":"10.1136\/ard.2010.138693_bib24","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1136\/ard.60.10.913","article-title":"Treatment of active rheumatoid arthritis with leflunomide: two year follow up of a double blind, placebo controlled trial versus sulfasalazine.","volume":"60","author":"Scott","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2010.138693_bib25","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1093\/rheumatology\/39.6.655","article-title":"A comparison of the efficacy and safety of leflunomide and methotrexate for the treatment of rheumatoid arthritis.","volume":"39","author":"Emery","year":"2000","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/ard.2010.138693_bib26","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1002\/art.1780281203","article-title":"How many joints in the hands and wrists should be included in a score of radiologic abnormalities used to assess rheumatoid arthritis?","volume":"28","author":"Sharp","year":"1985","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2010.138693_bib27","first-page":"743","article-title":"How to read radiographs according to the Sharp\/van der Heijde method.","volume":"26","author":"van der Heijde","year":"1999","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2010.138693_bib28","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1093\/rheumatology\/keg072","article-title":"A simplified disease activity index for rheumatoid arthritis for use in clinical practice.","volume":"42","author":"Smolen","year":"2003","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/ard.2010.138693_bib29","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/art.22552","article-title":"A proposed revision to the ACR20: the hybrid measure of American College of Rheumatology response.","volume":"57","author":"American College of Rheumatology Committee to Reevaluate Improvement Criteria","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2010.138693_bib30","first-page":"1243","article-title":"Which variables best predict change in rheumatoid arthritis therapy in daily clinical practice?","volume":"33","author":"Soubrier","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2010.138693_bib31","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1136\/ard.2004.027649","article-title":"Response criteria for rheumatoid arthritis in clinical practice: how useful are they?","volume":"64","author":"G\u00fclfe","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2010.138693_bib32","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1002\/art.21235","article-title":"Remission and active disease in rheumatoid arthritis: defining criteria for disease activity states.","volume":"52","author":"Aletaha","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2010.138693_bib33","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1093\/rheumatology\/kem007","article-title":"Assessing remission in clinical practice.","volume":"46","author":"Mierau","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/ard.2010.138693_bib34","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1093\/rheumatology\/kep442","article-title":"Superiority of SDAI over DAS-28 in assessment of remission in rheumatoid arthritis patients using power Doppler ultrasonography as a gold standard.","volume":"49","author":"Balsa","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/ard.2010.138693_bib35","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3899\/jrheum.090898","article-title":"Does clinical remission lead to normalization of EQ-5D in patients with rheumatoid arthritis and is selection of remission criteria important?","volume":"37","author":"Linde","year":"2010","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2010.138693_bib36","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1002\/art.24433","article-title":"Rheumatoid arthritis joint progression in sustained remission is determined by disease activity levels preceding the period of radiographic assessment.","volume":"60","author":"Aletaha","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2010.138693_bib37","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1148\/radiol.2482062110","article-title":"Radiographic evaluation of arthritis: inflammatory conditions.","volume":"248","author":"Jacobson","year":"2008","journal-title":"Radiology"},{"key":"10.1136\/ard.2010.138693_bib38","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1136\/ard.2007.071415","article-title":"Treatment-related improvement in physical function varies with duration of rheumatoid arthritis: a pooled analysis of clinical trial results.","volume":"67","author":"Aletaha","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2010.138693_bib39","first-page":"579","article-title":"Development of a disease activity score based on judgment in clinical practice by rheumatologists.","volume":"20","author":"van der Heijde","year":"1993","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2010.138693_bib40","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1002\/art.23417","article-title":"Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis: a twelve-month, multicenter, randomized, double-blind, placebo-controlled, phase II clinical trial.","volume":"58","author":"Cohen","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2010.138693_bib41","first-page":"1974","article-title":"How to apply Larsen score in evaluating radiographs of rheumatoid arthritis in long-term studies.","volume":"22","author":"Larsen","year":"1995","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2010.138693_bib42","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1002\/1529-0131(200003)43:3<495::AID-ANR4>3.0.CO;2-U","article-title":"Treatment with leflunomide slows radiographic progression of rheumatoid arthritis: results from three randomized controlled trials of leflunomide in patients with active rheumatoid arthritis. Leflunomide Rheumatoid Arthritis Investigators Group.","volume":"43","author":"Sharp","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2010.138693_bib43","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1002\/art.22025","article-title":"Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks.","volume":"54","author":"Cohen","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2010.138693_bib44","doi-asserted-by":"crossref","first-page":"865","DOI":"10.7326\/0003-4819-144-12-200606200-00003","article-title":"Effects of abatacept in patients with methotrexate-resistant active rheumatoid arthritis: a randomized trial.","volume":"144","author":"Kremer","year":"2006","journal-title":"Ann Intern Med"},{"key":"10.1136\/ard.2010.138693_bib45","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1136\/ard.2006.068064","article-title":"Study of active controlled monotherapy used for rheumatoid arthritis, an IL-6 inhibitor (SAMURAI): evidence of clinical and radiographic benefit from an x ray reader-blinded randomised controlled trial of tocilizumab.","volume":"66","author":"Nishimoto","year":"2007","journal-title":"Ann Rheum Dis"}],"updated-by":[{"DOI":"10.1136\/ard.2010.138693corr1","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000}}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724145694?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724145694?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.2010.138693","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,18]],"date-time":"2025-01-18T23:57:11Z","timestamp":1737244631000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724145694"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":45,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["S0003496724145694"],"URL":"https:\/\/doi.org\/10.1136\/ard.2010.138693","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2011,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Physical disability in rheumatoid arthritis is associated with cartilage damage rather than bone destruction","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.2010.138693","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Published by Elsevier Inc. For permission to use (where not already granted under a licence) please go to http:\/\/group.bmj.com\/group\/rights-licensing\/permissions. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}